BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17937631)

  • 1. Transplantation and tumors.
    Morales JM
    Nefrologia; 2006; 26 Suppl 2():12-20. PubMed ID: 17937631
    [No Abstract]   [Full Text] [Related]  

  • 2. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirolimus, the first mTOR inhibitor.
    Sánchez-Plumed JA; González Molina M; Alonso A; Arias M
    Nefrologia; 2006; 26 Suppl 2():21-32. PubMed ID: 17937632
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cancer after kidney transplantation].
    Sandrini S; Setti G; Bossini N; Maiorca P
    G Ital Nefrol; 2004; 21 Suppl 26():S67-73. PubMed ID: 15732048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignancy after solid organ transplantation: an overview.
    Zafar SY; Howell DN; Gockerman JP
    Oncologist; 2008 Jul; 13(7):769-78. PubMed ID: 18614590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer and mTOR Inhibitors in Transplant Recipients.
    de Fijter JW
    Transplantation; 2017 Jan; 101(1):45-55. PubMed ID: 27547865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus to replace calcineurin inhibitors? Too early yet.
    Cravedi P; Ruggenenti P; Remuzzi G
    Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of esophageal adenocarcinoma on long-term rapamycin monotherapy.
    Canha C; Ferreira R; Rovira J; Moya-Rull D; Castells A; Diekmann F; Oppenheimer F; Campistol JM; Revuelta I
    Transpl Int; 2015 Oct; 28(10):1240-4. PubMed ID: 25939687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Presentation of cancers in recipients of a solid-organ transplant].
    Lampreabe I; Gómez-Ullate P; Amenábar JJ; Zárraga S; Gaínza FJ; Urbizu JM
    Nefrologia; 2001; 21(6):528-37. PubMed ID: 11881422
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study.
    Delyon J; Rabate C; Euvrard S; Harwood CA; Proby C; Güleç AT; Seçkin D; Del Marmol V; Bouwes-Bavinck JN; Ferrándiz-Pulido C; Ocampo MA; Barete S; Legendre C; Francès C; Porcher R; Lebbe C;
    J Am Acad Dermatol; 2019 Aug; 81(2):448-455. PubMed ID: 30902727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the transplant physician in the management of skin cancers after organ transplantation.
    Morelon E; Mahe E; Touraine JL
    Cancer Treat Res; 2009; 146():377-90. PubMed ID: 19415217
    [No Abstract]   [Full Text] [Related]  

  • 12. Posttransplant lymphoproliferative disorders: report from a single center.
    De Carlis L; Slim AO; De Gasperi A; Muti G; Giacomoni A; Di Benedetto F; Lauterio A; Pirotta V; Corti A; Mazza E; Rondinara GF; Forti D
    Transplant Proc; 2001 Aug; 33(5):2815-6. PubMed ID: 11498170
    [No Abstract]   [Full Text] [Related]  

  • 13. Kaposi's sarcoma.
    Francès C; Lebbé C
    Cancer Treat Res; 2009; 146():299-309. PubMed ID: 19415211
    [No Abstract]   [Full Text] [Related]  

  • 14. Everolimus: efficacy and safety in cardiac transplantation.
    Schaffer SA; Ross HJ
    Expert Opin Drug Saf; 2010 Sep; 9(5):843-54. PubMed ID: 20701555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi Sarcoma in the Era of Rapamycin Remains a Therapeutic Challenge in Organ Transplant Recipients.
    Tunçer Vural A; Karataş Toğral A; Güleç AT; Haberal M
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):25-27. PubMed ID: 29527986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drugs and the risk of cancer after organ transplantation.
    Dantal J; Soulillou JP
    N Engl J Med; 2005 Mar; 352(13):1371-3. PubMed ID: 15800234
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors.
    Stucchi RSB; Lopes MH; Kumar D; Manuel O
    Transplantation; 2018 Feb; 102(2S Suppl 2):S72-S80. PubMed ID: 29381581
    [No Abstract]   [Full Text] [Related]  

  • 18. Traveler's Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors.
    Beeching NJ; Carratalà J; Razonable RR; Oriol I; Vilela EG
    Transplantation; 2018 Feb; 102(2S Suppl 2):S35-S41. PubMed ID: 29381576
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant melanoma in organ transplant recipients: incidence, outcomes, and management strategies: a review of literature.
    Džambová M; Sečníková Z; Jiráková A; Jůzlová K; Viklický O; Hošková L; Göpfertovà D; Hercogová J
    Dermatol Ther; 2016; 29(1):64-8. PubMed ID: 26460720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria Disease Recommendations for Solid Organ Transplant Recipients and Donors.
    Pierrotti LC; Levi ME; Di Santi SM; Segurado AC; Petersen E
    Transplantation; 2018 Feb; 102(2S Suppl 2):S16-S26. PubMed ID: 29381574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.